1 |
Ahima RS (2005). Central actions of adipocyte hormones. Trends Endocrinol Metab 16:307-313
DOI
ScienceOn
|
2 |
Berg AH, Combs TP, Du X, Brownlee M & Scherer PE (2001). The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
DOI
ScienceOn
|
3 |
Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM & Stern DM (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561
|
4 |
de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M & Staten M (1997). Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 14:200-208
DOI
ScienceOn
|
5 |
Hopkins AM, Baird AW & Nusrat A (2004). ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv Drug Deliv Rev 56:763-778
DOI
ScienceOn
|
6 |
Libby P (2002). Inflammation in atherosclerosis. Nature 420:868-874
DOI
ScienceOn
|
7 |
Zeitler H, Ko Y, Zimmermann C, Nickenig G, Glanzer K, Walger P, Sachinidis A & Vetter H (1997). Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res 2:389-394
|
8 |
Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G & Dowse G (1996). Serum leptin concentration, obesity and insulin resistance in Western cross sectional study. Br Med J 313:965-969
DOI
|
9 |
Glowinska B, Urban M, Peczynska J & Florys B (2005). Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54:1020-1026
DOI
ScienceOn
|
10 |
Berg AH & Scherer PE (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949
DOI
ScienceOn
|
11 |
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM & Giugliano D (2002). Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809
DOI
ScienceOn
|
12 |
Kevil CG, Patel RP & Bullard DC (2004). Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am J Physiol Cell Physiol 281:C1442-1447
|
13 |
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T & Matsuzawa Y (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476
DOI
|
14 |
Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919
DOI
ScienceOn
|
15 |
Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T & Matsuzawa Y (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770
DOI
|
16 |
Lyon CJ, Law RE & Hsueh WA (2003). Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200
DOI
ScienceOn
|
17 |
Lau DC, Dhillon B, Yan H, Szmitko PE & Verma S (2005). Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288:H2031-2041
DOI
ScienceOn
|
18 |
Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr & Ballantyne CM (1996). Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93:1334-1338
DOI
|
19 |
Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U, Sanisoglu SY, Gunay C, Baysan O, Kocar IH, Tatar H & Ozata M (2006). Tissue levels of adiponectin, tumour necrosis factoralpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol (Oxf) 64:196-202
DOI
ScienceOn
|
20 |
Kent JW Jr, Comuzzie AG, Mahaney MC, Almasy L, Rainwater DL, VandeBerg JL, MacCluer JW & Blangero J (2004). Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes 53:2691-2695
DOI
ScienceOn
|
21 |
Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB & Chen C (2005). Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126:121-129
DOI
ScienceOn
|
22 |
Skilton MR, Nakhla S, Sieveking DP, Caterson ID & Celermajer DS (2005). Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32:839-844
DOI
ScienceOn
|
23 |
Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K & Matsui J (2003). Globular adiponectin protected ob/ob mice from diabetes and ApoEdeficient mice from atherosclerosis. J Biol Chem 278:2461-2468
DOI
ScienceOn
|
24 |
Chandran M, Ciaraldi T, Philips SA & Henry RR (2003). Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-2450
DOI
ScienceOn
|
25 |
van der Vleuten GM, Veerkamp MJ, van Tits LJ, Toenhake H, den Heijer M, Stalenhoef AF & de Graaf J (2005). Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD. Atherosclerosis 183:355-360
DOI
ScienceOn
|
26 |
Ikata J, Wakatsuki T, Oishi Y, Oki T & Ito S (2004). Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 11:445-449
DOI
|
27 |
Libby P, Ridker PM & Maseri A (2002). Inflammation and atherosclerosis. Circulation 105:1135-1143
DOI
ScienceOn
|
28 |
Chan JL, Bullen J, Stoyneva V, Depaoli AM, Addy C & Mantzoros CS (2005). Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess. J Clin Endocrinol Metab 90:1618-1624
DOI
|
29 |
van Haelst PL, van Doormaal JJ, Asselbergs FW, van Roon AM, Veeger NJ, Henneman MM, Smit AJ, Tervaert JW, May JF & Gans RO (2003). Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond) 104:627-632
DOI
ScienceOn
|
30 |
Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L & Tavernier J (2004). Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 43:283-301
DOI
ScienceOn
|
31 |
Witkowska AM (2005). Soluble ICAM-1: a marker of vascular inflammation and lifestyle. Cytokine 31:127-134
DOI
ScienceOn
|
32 |
Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A & Sattar N (2001). Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052-3056
DOI
ScienceOn
|
33 |
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985). Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
DOI
|
34 |
van der Vleuten GM, van Tits LJ, den Heijer M, Lemmers H, Stalenhoef AF & de Graaf J (2005). Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile. J Lipid Res 46:2398-2404
DOI
ScienceOn
|
35 |
Hu E, Liang P & Spiegelman BM (1996). Adipo Q is a novel adipo-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703
DOI
ScienceOn
|
36 |
Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K & Nagai R (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415-419
DOI
ScienceOn
|
37 |
van de Stolpe A & van der Saag PT (1996). Intercellular adhesion molecule-1. J Mol Med 74:13-33
DOI
|